UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 677

Sortiert nach

A novel microfluidic platform for size and deformability based separation and the subsequent molecular characterization of viable circulating tumor cells

International journal of cancer, 2016-06, Vol.138 (12), p.2894-2904

2016

Volltextzugriff (PDF)

Mechanisms of resistance to anti-angiogenic therapy and development of third-generation anti-angiogenic drug candidates

Genes & cancer, 2010-01, Vol.1 (1), p.12-25

2010

Volltextzugriff (PDF)

Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme B

Nature communications, 2017-08, Vol.8 (1), p.269-11, Article 269

2017

Volltextzugriff (PDF)

EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer

European journal of cancer (1990), 2019-08, Vol.117, p.60-68

2019

Volltextzugriff (PDF)

RAISEing VEGF-D's importance as predictive biomarker for ramucirumab in metastatic colorectal cancer patients

Annals of oncology, 2018-03, Vol.29 (3), p.529

2018

Volltextzugriff (PDF)

Risk stratification of EGFR+ lung cancer diagnosed with panel-based next-generation sequencing

Lung cancer (Amsterdam, Netherlands), 2020-10, Vol.148, p.105-112

2020

Volltextzugriff (PDF)

A combination of low-dose bevacizumab and imatinib enhances vascular normalisation without inducing extracellular matrix deposition

British journal of cancer, 2017-02, Vol.116 (5), p.600-608

2017

Volltextzugriff (PDF)

Development of targeted angiogenic medicine

Journal of thrombosis and haemostasis, 2009-01, Vol.7 (1), p.21-33

2009

Volltextzugriff (PDF)

RAISEing VEGF-D’s importance as predictive biomarker for ramucirumab in metastatic colorectal cancer patients

Annals of oncology, 2018-03, Vol.29 (3), p.529-532

2018

Volltextzugriff (PDF)

Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma

Leukemia, 2015-03, Vol.29 (3), p.696-704

2015

Volltextzugriff (PDF)

Correction: Role of growth arrest-specific gene 6-mer axis in multiple myeloma

Leukemia, 2020-09, Vol.34 (9), p.2542-2542

2020

Volltextzugriff (PDF)

Effects of p38α/β inhibition on acute lymphoblastic leukemia proliferation and survival in vivo

Leukemia, 2015-12, Vol.29 (12), p.2307-2316

2015

Volltextzugriff (PDF)

Silencing of microRNA-21 confers radio-sensitivity through inhibition of the PI3K/AKT pathway and enhancing autophagy in malignant glioma cell lines

PloS one, 2012-10, Vol.7 (10), p.e47449-e47449

2012

Volltextzugriff (PDF)

Transferred BCR/ABL DNA from K562 extracellular vesicles causes chronic myeloid leukemia in immunodeficient mice

PloS one, 2014-08, Vol.9 (8), p.e105200-e105200

2014

Volltextzugriff (PDF)

Expression of TGF-β receptor ALK-5 has a negative impact on outcome of patients with acute myeloid leukemia

Leukemia, 2011-02, Vol.25 (2), p.375-379

2011

Volltextzugriff (PDF)

Growth arrest specific 2 is up-regulated in chronic myeloid leukemia cells and required for their growth

PloS one, 2014-01, Vol.9 (1), p.e86195-e86195

2014

Volltextzugriff (PDF)

Antiangiogenic treatment with endostatin inhibits progression of AML in vivo

Leukemia, 2005-08, Vol.19 (8), p.1312-1317

2005

Volltextzugriff (PDF)

Carboxyamidotriazole-orotate inhibits the growth of imatinib-resistant chronic myeloid leukaemia cells and modulates exosomes-stimulated angiogenesis

PloS one, 2012-08, Vol.7 (8), p.e42310

2012

Volltextzugriff (PDF)

Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels

Cell, 2007-11, Vol.131 (3), p.463-475

2007

Volltextzugriff (PDF)

Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM)

Annals of oncology, 2022-06, Vol.33 (6), p.602-615

2022

Volltextzugriff (PDF)

991P EGFR exon 20 insertions in non-small cell lung cancer (NSCLC): Impact of TP53 mutation status and value of immune checkpoint blockade (ICB)

Annals of oncology, 2022-09, Vol.33, p.S1006

2022

Volltextzugriff (PDF)

1431P The nNGM Preclinical Platform: Preclinical research to generate evidence for patients with non-small cell lung cancer harboring variants of unknown significance

Annals of oncology, 2023-10, Vol.34, p.S815-S815

2023

Volltextzugriff (PDF)

A Major CYP2D6 Autoepitope in Autoimmune Hepatitis Type 2 and Chronic Hepatitis C is a Three-dimensional Structure Homologous to Other Cytochrome P450 Autoantigens

Autoimmunity (Chur, Switzerland), 2002-01, Vol.35 (8), p.501-513

2002

Volltextzugriff (PDF)

1 – 25 von 677

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(590)
Mit Volltextzugriff
(620)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

A novel microfluidic platform for size and deformability based separation and the subsequent molecular characterization of viable circulating tumor cells

Mechanisms of resistance to anti-angiogenic therapy and development of third-generation anti-angiogenic drug candidates

Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme B

EPAC-lung: pooled analysis of circulating tumour cells in advanced non-small cell lung cancer

The ESMO Tumour-Agnostic Classifier and Screener (ETAC-S): a tool for assessing tumour-agnostic potential of molecularly guided therapies and for steering drug development

RAISEing VEGF-D's importance as predictive biomarker for ramucirumab in metastatic colorectal cancer patients

Risk stratification of EGFR+ lung cancer diagnosed with panel-based next-generation sequencing

A combination of low-dose bevacizumab and imatinib enhances vascular normalisation without inducing extracellular matrix deposition

Development of targeted angiogenic medicine

RAISEing VEGF-D’s importance as predictive biomarker for ramucirumab in metastatic colorectal cancer patients

Role of Growth arrest-specific gene 6-Mer axis in multiple myeloma

Correction: Role of growth arrest-specific gene 6-mer axis in multiple myeloma

Effects of p38α/β inhibition on acute lymphoblastic leukemia proliferation and survival in vivo

Silencing of microRNA-21 confers radio-sensitivity through inhibition of the PI3K/AKT pathway and enhancing autophagy in malignant glioma cell lines

P548: BEMCENTINIB COMBINED WITH LOW‐DOSE CYTARABINE IS EFFICACIOUS AND WELL TOLERATED IN RELAPSED AML PATIENTS UNFIT FOR INTENSIVE CHEMOTHERAPY. UPDATES FROM THE ONGOING PHASE II TRIAL (NCT02488408)

Transferred BCR/ABL DNA from K562 extracellular vesicles causes chronic myeloid leukemia in immunodeficient mice

Expression of TGF-β receptor ALK-5 has a negative impact on outcome of patients with acute myeloid leukemia

Growth arrest specific 2 is up-regulated in chronic myeloid leukemia cells and required for their growth

Antiangiogenic treatment with endostatin inhibits progression of AML in vivo

Carboxyamidotriazole-orotate inhibits the growth of imatinib-resistant chronic myeloid leukaemia cells and modulates exosomes-stimulated angiogenesis

Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels

Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM)

991P EGFR exon 20 insertions in non-small cell lung cancer (NSCLC): Impact of TP53 mutation status and value of immune checkpoint blockade (ICB)

1431P The nNGM Preclinical Platform: Preclinical research to generate evidence for patients with non-small cell lung cancer harboring variants of unknown significance

A Major CYP2D6 Autoepitope in Autoimmune Hepatitis Type 2 and Chronic Hepatitis C is a Three-dimensional Structure Homologous to Other Cytochrome P450 Autoantigens

Suchergebnisse filtern